verapamil and ro13-9904

verapamil has been researched along with ro13-9904 in 3 studies

Research

Studies (3)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's2 (66.67)18.2507
2000's1 (33.33)29.6817
2010's0 (0.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Choe, KJ; Gottesman, MM; Hong, IG; Kim, HS; Kim, WH; Kim, YI; Lee, SK; Lim, KH; Park, JG; Tsuruo, T1
Lugo, RA; Nahata, MC1
Hankø, E; Hansen, TW; Tommarello, S; Watchko, JF1

Other Studies

3 other study(ies) available for verapamil and ro13-9904

ArticleYear
MDR1 gene expression: its effect on drug resistance to doxorubicin in human hepatocellular carcinoma cell lines.
    Journal of the National Cancer Institute, 1994, May-04, Volume: 86, Issue:9

    Topics: ATP Binding Cassette Transporter, Subfamily B, Member 1; Carcinoma, Hepatocellular; Carrier Proteins; Cefoperazone; Ceftriaxone; Doxorubicin; Drug Resistance; Drug Synergism; Gene Expression; Humans; Immunohistochemistry; Liver Neoplasms; Membrane Glycoproteins; Neoplasm Proteins; Quinidine; RNA, Messenger; Trifluoperazine; Tumor Cells, Cultured; Verapamil

1994
Comment: verapamil interaction with ceftriaxone and clindamycin.
    The Annals of pharmacotherapy, 1993, Volume: 27, Issue:12

    Topics: Ceftriaxone; Clindamycin; Drug Interactions; Humans; Protein Binding; Verapamil

1993
Administration of drugs known to inhibit P-glycoprotein increases brain bilirubin and alters the regional distribution of bilirubin in rat brain.
    Pediatric research, 2003, Volume: 54, Issue:4

    Topics: Adrenergic beta-Antagonists; Animals; Anti-Bacterial Agents; ATP Binding Cassette Transporter, Subfamily B, Member 1; Bilirubin; Blood-Brain Barrier; Brain; Calcium Channel Blockers; Ceftriaxone; Enzyme Inhibitors; Erythromycin; Female; Humans; Male; Propranolol; Rats; Rats, Sprague-Dawley; Rifampin; Verapamil

2003